- Home
- LXEO vs CLPT Comparison
LXEO vs CLPT Comparison
Compare LXEO & CLPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LXEO
- CLPT
- Stock Information
- Founded
- LXEO 2017
- CLPT 1998
- Country
- LXEO United States
- CLPT United States
- Employees
- LXEO N/A
- CLPT N/A
- Industry
- LXEO
- CLPT Medical/Dental Instruments
- Sector
- LXEO
- CLPT Health Care
- Exchange
- LXEO Nasdaq
- CLPT Nasdaq
- Market Cap
- LXEO 597.8M
- CLPT 494.6M
- IPO Year
- LXEO 2023
- CLPT N/A
- Fundamental
- Price
- LXEO $9.34
- CLPT $14.12
- Analyst Decision
- LXEO Strong Buy
- CLPT Strong Buy
- Analyst Count
- LXEO 8
- CLPT 3
- Target Price
- LXEO $18.13
- CLPT $27.67
- AVG Volume (30 Days)
- LXEO 1.4M
- CLPT 1.0M
- Earning Date
- LXEO 11-05-2025
- CLPT 11-06-2025
- Dividend Yield
- LXEO N/A
- CLPT N/A
- EPS Growth
- LXEO N/A
- CLPT N/A
- EPS
- LXEO N/A
- CLPT N/A
- Revenue
- LXEO N/A
- CLPT $34,332,000.00
- Revenue This Year
- LXEO N/A
- CLPT $22.34
- Revenue Next Year
- LXEO N/A
- CLPT $25.50
- P/E Ratio
- LXEO N/A
- CLPT N/A
- Revenue Growth
- LXEO N/A
- CLPT 12.83
- 52 Week Low
- LXEO $1.45
- CLPT $9.76
- 52 Week High
- LXEO $10.38
- CLPT $30.10
- Technical
- Relative Strength Index (RSI)
- LXEO 58.98
- CLPT 32.55
- Support Level
- LXEO $7.66
- CLPT $14.71
- Resistance Level
- LXEO $9.63
- CLPT $17.78
- Average True Range (ATR)
- LXEO 0.64
- CLPT 1.73
- MACD
- LXEO -0.08
- CLPT -0.84
- Stochastic Oscillator
- LXEO 64.71
- CLPT 0.94
About LXEO Lexeo Therapeutics Inc.
Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.
About CLPT ClearPoint Neuro Inc.
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, ClearPoint Disposables, ClearPoint Software, and ClearPoint Therapeutic Solutions.